NEW YORK (GenomeWeb News) – French biotech Genomic Vision today announced it and Quest Diagnostics have extended their strategic alliance agreement originally forged in 2011.

Under the terms of the extension, Quest will invest in the planned development of a laboratory-developed test for an undisclosed hereditary genetic disease. The two firms also will collaborate on automating the testing process and improving turnaround times for tests that use Genomic Vision's DNA combing technique.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The partially reinstated US travel ban leaves space for uncertainty for researchers, Nature News says.

Researchers find a number of traits differ by sex and could affect mouse model studies, according to Reuters.

Tweaking the skin microbiome could help address some skin conditions, the New York Times reports.

In PNAS this week: DNA methylation profiles of tumor tissue, gene dynamics in prokaryotes, and more.